Has Naveen Nandanan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,660 in general payments to Naveen Nandanan, MD across 159 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Naveen Nandanan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Naveen Nandanan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Naveen Nandanan, MD

Urology · Fredericksburg, VANPI 1861769010

Payments from drug & device makers

$7,660in general payments, 2019–2025

Across 159 payments — averaging $48.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$2K
Coloplast$1K
Myriad Genetic Laboratories, Inc.$568
Procept Biorobotics Corporation$535
Axonics, Inc.$521
Dendreon Pharmaceuticals LLC$506
plus $2K from 29 others

What the payments were for

Travel & lodging$1,65922%
Food & beverage$5,80176%
Education$2003%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	24	$1,814
Coloplast	36	$1,239
Myriad Genetic Laboratories, Inc.	3	$568
Procept Biorobotics Corporation	6	$535
Axonics, Inc.	4	$521
Dendreon Pharmaceuticals LLC	11	$506
Johnson & Johnson	12	$476
Laborie Medical Technologies Corp.	3	$197
KARL Storz Endoscopy-america	2	$174
Pfizer	9	$172
Urogen Pharma, Inc.	5	$133
SRS Medical Systems, Inc.	2	$131
Medtronic	2	$127
Progenics Pharmaceuticals, Inc.	5	$102
Astellas Pharma US Inc	4	$101
Sumitomo Pharma America, Inc.	3	$100
Endo Pharmaceuticals Inc.	1	$97
Calyxo, Inc.	1	$93
Cook Medical LLC	2	$71
Merck	3	$58
Bayer	2	$46
Blue Earth Diagnostics	2	$46
Tolmar, Inc.	2	$45
Sun Pharmaceutical Industries Inc.	2	$43
Accord Healthcare, Inc.	2	$41
Amgen	2	$31
Lantheus Medical Imaging, Inc.	1	$30
Ferring Pharmaceuticals Inc.	1	$24
Novartis	1	$23
Azurity Pharmaceuticals, Inc.	1	$22
Teleflex LLC	1	$22
Immunitybio, Inc.	1	$21
Bluewind Medical	1	$20
AbbVie	1	$19
Antares Pharma, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AMS$1,210
Prolaris$556
Bulkamid$435
Axonics$435
PROVENGE$272
AquaBeam Robotic System$246
TITAN$227
AQUABEAM SYSTEM$157
LithoVue$116
Flex-X$114
INTERSTIM$105
Optilume BPH Drug Coated Balloon Catheter$101

How this compares

$7,660 in reported general payments places this provider in the 65th percentile of 300 urology providers in Virginia.

See all urology providers in Virginia →

Medicare billing

Part B allowed, 2024

$329,217

Medicare patients

779

Services billed

4,934

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	333	$4,279
Finasteride	134	$1,428
Oxybutynin Chloride ErOxybutynin Chloride	43	$1,245
Methenamine Hippurate	12	$919
Estradiol	13	$842
NitrofurantoinNitrofurantoin Macrocrystal	18	$728
Alfuzosin Hcl ErAlfuzosin Hcl	14	$386
Doxazosin Mesylate	21	$333
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	50	$269
Tramadol Hcl	34	$70
Ciprofloxacin Hcl	23	$49
Oxycodone Hcl	23	$45

Paid to pharmacies, not to this prescriber.

Other urology in Fredericksburg

Robert GivenVirginia Beach$8.7M
Michael WilliamsVirginia Beach$2.7M
Michael FabrizioVirginia Beach$1.6M
Gregg EureVirginia Beach$1.5M
Nilay GandhiWoodbridge$1.3M
Jessica DelongVirginia Beach$644K
Eugene KramolowskyRichmond$594K
Nicolas OrtizCharlottesville$331K
Stephen CulpCharlottesville$284K
Michael FranksRichmond$136K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →